Close

AstraZeneca lands first big partner for digital health platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg...

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK...

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences...

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized...

The Human Medicines Regulations 2025, which came into force...

The Boston-based hospital strategies to run two pilot of the system in a real-world setting to see how it does in people with heart failing and also asthma.”At the end of the day, we both desire to solve the exact same troubles in persistent illness management– to make sure the ideal option obtains to the ideal person at the best time in order to improve treatment,” she created in an emailed declaration.

Silacci created that Mass General chose AstraZeneca’s platform for its ability to effectively identify at-risk individuals and accelerate evidence-based clinical practice.

The Boston-based hospital strategies to run two pilot of the system in a real-world setup to see exactly how it carries out in patients with heart failure and also asthma.”At the end of the day, we both desire to resolve the very same problems in persistent ailment administration– to make sure the right remedy gets to the right patient at the best time in order to enhance treatment,” she composed in an emailed statement.

Silacci composed that Mass General picked AstraZeneca’s platform for its capability to successfully recognize at-risk individuals and speed up evidence-based professional technique.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back